News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website


German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 Germany finally approved Optune under their national health system. 

I thought the USA was slow - Medicare approved it last year - about 4 years after it was approved for newly diagnosed glioblastoma.

It is troubling that there is such a delay between FDA approval and insurance payment approval. The same thing happened with Temodar and Avastin. In the USA, the Medicare approval process should start at the same time as the application to the FDA so the FDA and Medicare approvals come out at the same time.


Posted on: 03/20/2020

German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740